Cargando…
Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity
Drug-induced liver injury (DILI) is an important cause of morbidity and mortality. DILI can even cause acute liver failure and the need for liver transplantation. Identifying DILI may be particularly difficult because it is actually an exclusion diagnosis and individuals are usually exposed to sever...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969320/ https://www.ncbi.nlm.nih.gov/pubmed/31988867 http://dx.doi.org/10.5005/jp-journals-10018-1295 |
_version_ | 1783489304901713920 |
---|---|
author | Duzenli, Tolga Tanoglu, Alpaslan Akyol, Taner Kara, Muammer Yazgan, Yusuf |
author_facet | Duzenli, Tolga Tanoglu, Alpaslan Akyol, Taner Kara, Muammer Yazgan, Yusuf |
author_sort | Duzenli, Tolga |
collection | PubMed |
description | Drug-induced liver injury (DILI) is an important cause of morbidity and mortality. DILI can even cause acute liver failure and the need for liver transplantation. Identifying DILI may be particularly difficult because it is actually an exclusion diagnosis and individuals are usually exposed to several drugs during a lifetime. Causality assessment methods are needed for objective diagnosis. The most common methods are; updated Roussel Uclaf causality assessment method (RUCAM), Narenjo adverse drug reaction probability scale and Maria and Victorino (M&V) causality assessment scale. Phenprobamate is a widely used muscle relaxant. Herein we report a rare case of repeated DILI caused by phenprobamate and review the objective diagnostic process for hepatotoxicities. Physicians should be aware of the potential adverse effects of this drug, including hepatotoxicity. How to cite this article: Duzenli T, Tanoglu A, et al. Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity. Euroasian J Hepatogastroenterol 2019;9(1) :49-51. |
format | Online Article Text |
id | pubmed-6969320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-69693202020-01-27 Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity Duzenli, Tolga Tanoglu, Alpaslan Akyol, Taner Kara, Muammer Yazgan, Yusuf Euroasian J Hepatogastroenterol Case Report Drug-induced liver injury (DILI) is an important cause of morbidity and mortality. DILI can even cause acute liver failure and the need for liver transplantation. Identifying DILI may be particularly difficult because it is actually an exclusion diagnosis and individuals are usually exposed to several drugs during a lifetime. Causality assessment methods are needed for objective diagnosis. The most common methods are; updated Roussel Uclaf causality assessment method (RUCAM), Narenjo adverse drug reaction probability scale and Maria and Victorino (M&V) causality assessment scale. Phenprobamate is a widely used muscle relaxant. Herein we report a rare case of repeated DILI caused by phenprobamate and review the objective diagnostic process for hepatotoxicities. Physicians should be aware of the potential adverse effects of this drug, including hepatotoxicity. How to cite this article: Duzenli T, Tanoglu A, et al. Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity. Euroasian J Hepatogastroenterol 2019;9(1) :49-51. Jaypee Brothers Medical Publishers 2019 /pmc/articles/PMC6969320/ /pubmed/31988867 http://dx.doi.org/10.5005/jp-journals-10018-1295 Text en Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd. © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Duzenli, Tolga Tanoglu, Alpaslan Akyol, Taner Kara, Muammer Yazgan, Yusuf Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity |
title | Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity |
title_full | Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity |
title_fullStr | Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity |
title_full_unstemmed | Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity |
title_short | Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity |
title_sort | drug-induced liver injury caused by phenprobamate: strong probability due to repeated toxicity |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969320/ https://www.ncbi.nlm.nih.gov/pubmed/31988867 http://dx.doi.org/10.5005/jp-journals-10018-1295 |
work_keys_str_mv | AT duzenlitolga druginducedliverinjurycausedbyphenprobamatestrongprobabilityduetorepeatedtoxicity AT tanoglualpaslan druginducedliverinjurycausedbyphenprobamatestrongprobabilityduetorepeatedtoxicity AT akyoltaner druginducedliverinjurycausedbyphenprobamatestrongprobabilityduetorepeatedtoxicity AT karamuammer druginducedliverinjurycausedbyphenprobamatestrongprobabilityduetorepeatedtoxicity AT yazganyusuf druginducedliverinjurycausedbyphenprobamatestrongprobabilityduetorepeatedtoxicity |